Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jerome H. Check & Diane L. Check. (2023) The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Review of Endocrinology & Metabolism 18:1, pages 5-18.
Read now
Read now
Can Cui, Xiaojing Cheng, Liang Yan, Huirong Ding, Xiaoya Guan, Wenlong Zhang, Xiuyun Tian & Chunyi Hao. (2019) Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway. Cancer Management and Research 11, pages 6323-6341.
Read now
Read now
Nibedita Gupta & Doris Mayer. (2013) Interaction of JAK with steroid receptor function. JAK-STAT 2:4.
Read now
Read now
Andrea R Daniel, Christy R Hagan & Carol A Lange. (2011) Progesterone receptor action: defining a role in breast cancer. Expert Review of Endocrinology & Metabolism 6:3, pages 359-369.
Read now
Read now
Wendy Béguelin, María Celeste Díaz Flaqué, Cecilia J. Proietti, Florencia Cayrol, Martín A. Rivas, Mercedes Tkach, Cinthia Rosemblit, Johanna M. Tocci, Eduardo H. Charreau, Roxana Schillaci & Patricia V. Elizalde. (2010) Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3. Molecular and Cellular Biology 30:23, pages 5456-5472.
Read now
Read now
Hilary E. Wade, Sakiko Kobayashi, Matthew L. Eaton, Michelle S. Jansen, Edward K. Lobenhofer, Mathieu Lupien, Timothy R. Geistlinger, Wencheng Zhu, Joseph R. Nevins, Myles Brown, Deborah C. Otteson & Donald P. McDonnell. (2010) Multimodal Regulation of E2F1 Gene Expression by Progestins. Molecular and Cellular Biology 30:8, pages 1866-1877.
Read now
Read now
Cecilia J. Proietti, Cinthia Rosemblit, Wendy Beguelin, Martín A. Rivas, María Celeste Díaz Flaqué, Eduardo H. Charreau, Roxana Schillaci & Patricia V. Elizalde. (2009) Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth. Molecular and Cellular Biology 29:5, pages 1249-1265.
Read now
Read now
Alicia Subtil-Rodríguez, Lluís Millán-Ariño, Ignacio Quiles, Cecilia Ballaré, Miguel Beato & Albert Jordan. (2008) Progesterone Induction of the 11β-Hydroxysteroid Dehydrogenase Type 2 Promoter in Breast Cancer Cells Involves Coordinated Recruitment of STAT5A and Progesterone Receptor to a Distal Enhancer and Polymerase Tracking. Molecular and Cellular Biology 28:11, pages 3830-3849.
Read now
Read now
Articles from other publishers (87)
Mellisa Renteria, Ofek Belkin, David Jang, Justin Aickareth, Muaz Bhalli & Jun Zhang. (2022) CmPn signaling networks in the tumorigenesis of breast cancer. Frontiers in Endocrinology 13.
Crossref
Crossref
Johnathan Abou-Fadel, Xiaoting Jiang, Brian Grajeda, Akhil Padarti, Cameron C. Ellis, Esmeralda Flores, Alyssa-Marie D. Cailing-De La O & Jun Zhang. (2022) CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling. Cell Communication and Signaling 20:1.
Crossref
Crossref
Kaixuan Li, Dongjiang Zong, Jianrong Sun, Danxiang Chen, Minkai Ma & Liqun Jia. (2022) Rewiring of the Endocrine Network in Triple-Negative Breast Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Claudia Bello-Alvarez, Carmen J. Zamora-Sánchez & Ignacio Camacho-Arroyo. (2022) Rapid Actions of the Nuclear Progesterone Receptor through cSrc in Cancer. Cells 11:12, pages 1964.
Crossref
Crossref
Emma Grant, Fatma A. Bucklain, Lucy Ginn, Peter Laity, Barbara Ciani & Helen E. Bryant. (2022) Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines. PLOS ONE 17:5, pages e0268300.
Crossref
Crossref
Santiago Madera, Franco Izzo, María F. Chervo, Agustina Dupont, Violeta A. Chiauzzi, Sofia Bruni, Ezequiel Petrillo, Sharon S. Merin, Mara De Martino, Diego Montero, Claudio Levit, Gabriel Lebersztein, Fabiana Anfuso, Agustina Roldán Deamicis, María F. Mercogliano, Cecilia J. Proietti, Roxana Schillaci, Patricia V. Elizalde & Rosalía I. Cordo Russo. (2022) Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death & Disease 13:5.
Crossref
Crossref
Heng Chen, Dong Wang, Limei Fan, Zixin Liu, Weiran Zhang, Jinhua Xu & Yunyi Liu. (2022) Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative breast cancer cells. Scientific Reports 12:1.
Crossref
Crossref
Ghada Mohammed, Noha A. Mousa, Iman M. Talaat, Haya Ibrahim & Maha Saber-Ayad. (2021) Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling. Frontiers in Endocrinology 12.
Crossref
Crossref
Charlène Thiebaut, Virginie Vlaeminck-Guillem, Olivier Trédan, Coralie Poulard & Muriel Le Romancer. (2021) Non-genomic signaling of steroid receptors in cancer. Molecular and Cellular Endocrinology 538, pages 111453.
Crossref
Crossref
Annachiara Tesoriere, Alberto Dinarello & Francesco Argenton. (2021) The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions. Biomedicines 9:8, pages 956.
Crossref
Crossref
Nicole L. Moore, Adrienne R. Hanson, Esmaeil Ebrahimie, Theresa E. Hickey & Wayne D. Tilley. (2020) Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor. The Journal of Steroid Biochemistry and Molecular Biology 199, pages 105548.
Crossref
Crossref
Mauro E. Cenciarini & Cecilia J. Proietti. (2019) Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation. Steroids 152, pages 108503.
Crossref
Crossref
Angela Dittmer, Theresia Lange, Benjamin Leyh & J�rgen Dittmer. (2019) Protein‑ and growth‑modulatory effects of carcinoma‑associated fibroblasts on breast cancer cells: Role of interleukin‑6. International Journal of Oncology.
Crossref
Crossref
Rosalía I. Cordo Russo, María F. Chervo, Santiago Madera, Eduardo H. Charreau & Patricia V. Elizalde. (2019) Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?. Hormones and Cancer 10:2-3, pages 64-70.
Crossref
Crossref
Sebastián Giulianelli, Marina Riggio, Tomas Guillardoy, Cecilia Pérez Piñero, María A. Gorostiaga, Gonzalo Sequeira, Gabriela Pataccini, María F. Abascal, María F. Toledo, Britta M. Jacobsen, Ana C. Guerreiro, António Barros, Virginia Novaro, Fátima L. Monteiro, Francisco Amado, Hugo Gass, Martin Abba, Luisa A. Helguero & Claudia Lanari. (2019)
FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to
MYC
regulatory sequences
. International Journal of Cancer.
Crossref
Crossref
Shuntao Wang, Lili Yu, Wei Shi, Xueqin Li & Lixiu Yu. (2018) Prognostic roles of signal transducers and activators of transcription family in human breast cancer. Bioscience Reports 38:6.
Crossref
Crossref
Hongmin Lu, Shibo Wu, Huafei Chen, Ying Huang, Guoqin Qiu, Lingxiang Liu & Yong Li. (2018) Crizotinib induces apoptosis of lung cancer cells through JAK-STAT pathway. Oncology Letters.
Crossref
Crossref
Sasagu Kurozumi, Hiroshi Matsumoto, Kenichi Inoue, Katsunori Tozuka, Yuji Hayashi, Masafumi Kurosumi, Tetsunari Oyama, Takaaki Fujii, Jun Horiguchi & Hiroyuki Kuwano. (2018) Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer. PLOS ONE 13:8, pages e0201846.
Crossref
Crossref
Katherine A. Leehy, Thu H. Truong, Laura J. Mauro & Carol A. Lange. (2018) Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 176, pages 88-93.
Crossref
Crossref
Yujuan Chen, Ya Liu, Yu Wang, Wen Li, Xiaolu Wang, Xuejuan Liu, Yao Chen, Chibin Ouyang & Jing Wang. (2017) Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer. Medicine 96:45, pages e8488.
Crossref
Crossref
Hua-Tao Wu, Jing Liu, Guan-Wu Li, Jia-Xin Shen & Yi-Teng Huang. (2017) The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma. Oncotarget 8:22, pages 36279-36288.
Crossref
Crossref
Ignacio Camacho-Arroyo, Valeria Hansberg-Pastor, Edgar Ricardo Vázquez-Martínez & Marco Cerbón. 2017. Hormones, Brain and Behavior. Hormones, Brain and Behavior
181
214
.
Patricia V Elizalde, Rosalía I Cordo Russo, Maria F Chervo & Roxana Schillaci. (2016) ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy. Endocrine-Related Cancer 23:12, pages T243-T257.
Crossref
Crossref
Ting Pan, Yufeng Liu, Li Mei Zhong, Mao Hua Shi, Xiao Bing Duan, Kang Wu, Qiong Yang, Chao Liu, Jian Yang Wei, Xing Ru Ma, Kun Shi, Hui Zhang & Jie Zhou. (2016) Myeloid-derived suppressor cells are essential for maintaining feto-maternal immunotolerance via STAT3 signaling in mice. Journal of Leukocyte Biology 100:3, pages 499-511.
Crossref
Crossref
L Venturutti, L V Romero, A J Urtreger, M F Chervo, R I Cordo Russo, M F Mercogliano, G Inurrigarro, M G Pereyra, C J Proietti, F Izzo, M C Díaz Flaqué, V Sundblad, J C Roa, P Guzmán, E D Bal de Kier Joffé, E H Charreau, R Schillaci & P V Elizalde. (2015) Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. Oncogene 35:17, pages 2208-2222.
Crossref
Crossref
Tsung-I Hsu, Yi-Chang Wang, Chia-Yang Hung, Chun-Hui Yu, Wu-Chou Su, Wen-Chang Chang & Jan-Jong Hung. (2016) Positive feedback regulation between IL10 and EGFR promotes lung cancer formation. Oncotarget 7:15, pages 20840-20854.
Crossref
Crossref
Fanfan Zhu, Chunyan Dai, Yufei Fu, Jacky F.C. Loo, Dajin Xia, Sizhi P. Gao, Zhongjun Ma & Zhe Chen. (2016) Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling. Oncotarget 7:8, pages 9462-9476.
Crossref
Crossref
Caroline H. Diep, Todd P. Knutson & Carol A. Lange. (2016) Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Molecular Cancer Research 14:2, pages 141-162.
Crossref
Crossref
Cecilia J. Proietti, Franco Izzo, María Celeste Díaz Flaqué, Rosalía Cordo Russo, Leandro Venturutti, María Florencia Mercogliano, Mara De Martino, Viviana Pineda, Sergio Muñoz, Pablo Guzmán, Juan C. Roa, Roxana Schillaci & Patricia V. Elizalde. (2015) Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth. Molecular Endocrinology 29:10, pages 1468-1485.
Crossref
Crossref
Ashley M. Fortress, John D. Heisler & Karyn M. Frick. (2015) The mTOR and canonical Wnt signaling pathways mediate the mnemonic effects of progesterone in the dorsal hippocampus. Hippocampus 25:5, pages 616-629.
Crossref
Crossref
Mona T. Hamzeh, Rashmi Sridhara & Larry D. Alexander. (2015) Cyclic stretch-induced TGF-β1 and fibronectin expression is mediated by β1-integrin through c-Src- and STAT3-dependent pathways in renal epithelial cells. American Journal of Physiology-Renal Physiology 308:5, pages F425-F436.
Crossref
Crossref
Chun Huang, Xuan Wang, Baocun Sun, Man Li, Xiulan Zhao, Yanjun Gu, Yanfen Cui & Yan Li. (2014) Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer. Targeted Oncology 10:1, pages 85-97.
Crossref
Crossref
Franco Izzo, Florencia Mercogliano, Leandro Venturutti, Mercedes Tkach, Gloria Inurrigarro, Roxana Schillaci, Leandro Cerchietti, Patricia V Elizalde & Cecilia J Proietti. (2014) Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Research 16:6.
Crossref
Crossref
Nicole L. Moore, Dean P. Edwards & Nancy L. Weigel. (2014) Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 144, pages 471-482.
Crossref
Crossref
María C Díaz Flaqué, Natalia M Galigniana, Wendy Béguelin, Rocío Vicario, Cecilia J Proietti, Rosalía Cordo Russo, Martín A Rivas, Mercedes Tkach, Pablo Guzmán, Juan C Roa, Esteban Maronna, Viviana Pineda, Sergio Muñoz, María Florencia Mercogliano, Eduardo H Charreau, Patricio Yankilevich, Roxana Schillaci & Patricia V Elizalde. (2013) Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast Cancer Research 15:6.
Crossref
Crossref
Chao Li, Zhou Wang, Yan Liu, Peng Wang & Runqi Zhang. (2013) STAT3 expression correlates with prognosis of thymic epithelial tumors. Journal of Cardiothoracic Surgery 8:1.
Crossref
Crossref
Alison E. Obr, Sandra L. Grimm, Kathleen A. Bishop, J. Wesley Pike, John P. Lydon & Dean P. Edwards. (2013) Progesterone Receptor and Stat5 Signaling Cross Talk Through RANKL in Mammary Epithelial Cells. Molecular Endocrinology 27:11, pages 1808-1824.
Crossref
Crossref
Ashlee R. Lain, Chad J. Creighton & Orla M. Conneely. (2013) Research Resource: Progesterone Receptor Targetome Underlying Mammary Gland Branching Morphogenesis. Molecular Endocrinology 27:10, pages 1743-1761.
Crossref
Crossref
Qingqing Wei, Guiyu Zhu, Xinxing Cui, Li Kang, Dingguo Cao & Yunliang Jiang. (2013) Expression of CCT6A mRNA in chicken granulosa cells is regulated by progesterone. General and Comparative Endocrinology 189, pages 15-23.
Crossref
Crossref
María C. Diaz Flaqué, Rocío Vicario, Cecilia J. Proietti, Franco Izzo, Roxana Schillaci & Patricia V. Elizalde. (2013) Progestin drives breast cancer growth by inducing p21CIP1 expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2. Steroids 78:6, pages 559-567.
Crossref
Crossref
Catherine Bellance, Junaid A. Khan, Geri Meduri, Anne Guiochon-Mantel, Marc Lombès & Hugues Loosfelt. (2013) Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes. Molecular Biology of the Cell 24:9, pages 1363-1374.
Crossref
Crossref
Mercedes Tkach, Cinthia Rosemblit, Martín A Rivas, Cecilia J Proietti, María Celeste Díaz Flaqué, María Florencia Mercogliano, Wendy Beguelin, Esteban Maronna, Pablo Guzmán, Felipe G Gercovich, Ernesto Gil Deza, Patricia V Elizalde & Roxana Schillaci. (2013) p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth. Endocrine-Related Cancer 20:2, pages 197-212.
Crossref
Crossref
Frank Z. StanczykJanet P. Hapgood, Sharon Winer & Daniel R. MishellJr.Jr.. (2013) Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. Endocrine Reviews 34:2, pages 171-208.
Crossref
Crossref
Yao-Tsung Yeh, Chien-Wei Chang, Ren-Jie Wei & Shen-Nien Wang. (2013) Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
Mercedes Tkach, Lorena Coria, Cinthia Rosemblit, Martín A. Rivas, Cecilia J. Proietti, María Celeste Díaz Flaqué, Wendy Beguelin, Isabel Frahm, Eduardo H. Charreau, Juliana Cassataro, Patricia V. Elizalde & Roxana Schillaci. (2012) Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells. The Journal of Immunology 189:3, pages 1162-1172.
Crossref
Crossref
Justus Stenzig, Andreas Schweikert, Angelika Piasecki, Grit Höppner, Thomas Eschenhagen & Thomas Rau. (2012) Progesterone receptor variants associated with the PROGINS haplotype exhibit functional properties similar to those of wild-type progesterone receptor. Pharmacogenetics and Genomics 22:8, pages 629-641.
Crossref
Crossref
Martin A Rivas, Leandro Venturutti, Yi-Wen Huang, Roxana Schillaci, Tim Hui-Ming Huang & Patricia V Elizalde. (2012) Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Research 14:3.
Crossref
Crossref
Christina Magkou, Ioanna Giannopoulou, Irene Theohari, Alexandra Fytou, Petros Rafailidis, Alexandros Nomikos, Christos Papadimitriou & Lydia Nakopoulou. (2012) Prognostic significance of phosphorylated STAT-1 expression in premenopausal and postmenopausal patients with invasive breast cancer. Histopathology 60:7, pages 1125-1132.
Crossref
Crossref
Alison E. Obr & Dean P. Edwards. (2012) The biology of progesterone receptor in the normal mammary gland and in breast cancer. Molecular and Cellular Endocrinology 357:1-2, pages 4-17.
Crossref
Crossref
Adriana R. Mantegazza, Susan H. Guttentag, Jamel El-Benna, Miwa Sasai, Akiko Iwasaki, Hao Shen, Terri M. Laufer & Michael S. Marks. (2012) Adaptor Protein-3 in Dendritic Cells Facilitates Phagosomal Toll-like Receptor Signaling and Antigen Presentation to CD4+ T Cells. Immunity 36:5, pages 782-794.
Crossref
Crossref
Laura Robaldo, Franco Izzo, María Dellafiore, Cecilia Proietti, Patricia V. Elizalde, Javier M. Montserrat & Adolfo M. Iribarren. (2012) Influence of conformationally restricted pyrimidines on the activity of 10–23 DNAzymes. Bioorganic & Medicinal Chemistry 20:8, pages 2581-2586.
Crossref
Crossref
Laura Novellasdemunt, Mercè Obach, Lluís Millán-Ariño, Anna Manzano, Francesc Ventura, Jose Luis Rosa, Albert Jordan, Àurea Navarro-Sabate & Ramon Bartrons. (2012) Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells. Biochemical Journal 442:2, pages 345-356.
Crossref
Crossref
Krista K. Hill, Sarah C. Roemer, Mair E.A. Churchill & Dean P. Edwards. (2012) Structural and functional analysis of domains of the progesterone receptor. Molecular and Cellular Endocrinology 348:2, pages 418-429.
Crossref
Crossref
Ashish Bhattacharjee, Srabani Pal, Gerald M. Feldman & Martha K. Cathcart. (2011) Hck Is a Key Regulator of Gene Expression in Alternatively Activated Human Monocytes. Journal of Biological Chemistry 286:42, pages 36709-36723.
Crossref
Crossref
Juan P. Cerliani, Tomás Guillardoy, Sebastián Giulianelli, José P. Vaque, J. Silvio Gutkind, Silvia I. Vanzulli, Rubén Martins, Eduardo Zeitlin, Caroline A. Lamb & Claudia Lanari. (2011) Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer. Cancer Research 71:10, pages 3720-3731.
Crossref
Crossref
Cecilia J. Proietti, Wendy Béguelin, María Celeste Díaz Flaqué, Florencia Cayrol, Martín A. Rivas, Mercedes Tkach, Eduardo H. Charreau, Roxana Schillaci & Patricia V. Elizalde. (2011) Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer. Steroids 76:4, pages 381-392.
Crossref
Crossref
Xuan Wang, Chun Huang, Baocun Sun, Yanjun Gu, Yanfen Cui, Xiulan Zhao, Yan Li & Shiwu Zhang. (2010) ORIGINAL ARTICLE: The Effect of High Gravidity on the Carcinogenesis of Mammary Gland in TA2 Mice. American Journal of Reproductive Immunology 63:5, pages 396-409.
Crossref
Crossref
Shaila Mani & Wendy Portillo. (2010) Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters. Frontiers in Neuroendocrinology 31:2, pages 157-171.
Crossref
Crossref
Ju-Hwa Kim, Seok Chul Lee, Jungsil Ro, Han Sung Kang, Hyung Sik Kim & Sungpil Yoon. (2010) Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines. Biochemical Pharmacology 79:3, pages 373-380.
Crossref
Crossref
Andrea R. Daniel, Todd P. Knutson & Carol A. Lange. (2009) Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Molecular and Cellular Endocrinology 308:1-2, pages 47-52.
Crossref
Crossref
Ignacio Quiles, Lluís Millán-Ariño, Alicia Subtil-Rodríguez, Belén Miñana, Nora Spinedi, Cecilia Ballaré, Miguel Beato & Albert Jordan. (2009) Mutational Analysis of Progesterone Receptor Functional Domains in Stable Cell Lines Delineates Sets of Genes Regulated by Different Mechanisms. Molecular Endocrinology 23:6, pages 809-826.
Crossref
Crossref
M.J. Tetel & C.A. Lange. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1439
1466
.
Megumi Iiizumi, Wen Liu, Sudha K. Pai, Eiji Furuta & Kounosuke Watabe. (2008) Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1786:2, pages 87-104.
Crossref
Crossref
Ze Li, E. Blake Watkins, Hua Liu, Amar G. Chittiboyina, Paulo B. Carvalho & Mitchell A. Avery. (2008)
1,3-Diaxially Substituted
trans
-Decalins: Potential Nonsteroidal Human Progesterone Receptor Inhibitors
. The Journal of Organic Chemistry 73:19, pages 7764-7767.
Crossref
Crossref
Mario Lapecorella, Antonio Tabilio, Alessandro Lucchesi, Mariasanta Napolitano, Marianna Colagrande, Mauro Di Ianni & Guglielmo Mariani. (2008) Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment. Blood Coagulation & Fibrinolysis 19:5, pages 453-457.
Crossref
Crossref
Bahar Movaghar, Taki Tiraihi & Seyed A. Mesbah-Namin. (2008) Transdifferentiation of bone marrow stromal cells into Schwann cell phenotype using progesterone as inducer. Brain Research 1208, pages 17-24.
Crossref
Crossref
Birgit Gellersen & Jan Brosens. 2008. Endometrium, The. Endometrium, The
379
396
.
Emily J. Faivre, Andrea R. Daniel, Christopher J. Hillard & Carol A. Lange. (2008) Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors. Molecular Endocrinology 22:4, pages 823-837.
Crossref
Crossref
Carol A LangeDouglas Yee. (2008) Progesterone and Breast Cancer. Women's Health 4:2, pages 151-162.
Crossref
Crossref
Martín A. Rivas, Romina P. Carnevale, Cecilia J. Proietti, Cinthia Rosemblit, Wendy Beguelin, Mariana Salatino, Eduardo H. Charreau, Isabel Frahm, Sandra Sapia, Peter Brouckaert, Patricia V. Elizalde & Roxana Schillaci. (2008) TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways. Experimental Cell Research 314:3, pages 509-529.
Crossref
Crossref
Carol A. Lange. (2008) Integration of progesterone receptor action with rapid signaling events in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 108:3-5, pages 203-212.
Crossref
Crossref
Carol A. Lange, Carol A. Sartorius, Hany Abdel-Hafiz, Monique A. Spillman, Kathryn B. Horwitz & Britta M. Jacobsen. 2008. Innovative Endocrinology of Cancer. Innovative Endocrinology of Cancer
94
111
.
Evdokia Dimitriadis, Andrew M Sharkey, Yee Lee Tan, Lois A Salamonsen & J Robert A Sherwin. (2007) Immunolocalisation of phosphorylated STAT3, interleukin 11 and leukaemia inhibitory factor in endometrium of women with unexplained infertility during the implantation window. Reproductive Biology and Endocrinology 5:1.
Crossref
Crossref
Chun-Liang Chen, Abbey Loy, Ling Cen, Christina Chan, Fu-Chuan Hsieh, Gong Cheng, Bryant Wu, Stephen J Qualman, Keita Kunisada, Keiko Yamauchi-Takihara & Jiayuh Lin. (2007) Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer 7:1.
Crossref
Crossref
Nima M. Gharavi, Jackelyn A. Alva, Kevin P. Mouillesseaux, Chi Lai, Michael Yeh, Winnie Yeung, Jaclyn Johnson, Wan Lam Szeto, Longsheng Hong, Michael Fishbein, Lai Wei, Lawrence M. Pfeffer & Judith A. Berliner. (2007) Role of the JAK/STAT Pathway in the Regulation of Interleukin-8 Transcription by Oxidized Phospholipids in Vitro and in Atherosclerosis in Vivo. Journal of Biological Chemistry 282:43, pages 31460-31468.
Crossref
Crossref
Carol A. LangeDaniel GioeliStephen R. HammesPaul C. Marker. (2007) Integration of Rapid Signaling Events with Steroid Hormone Receptor Action in Breast and Prostate Cancer. Annual Review of Physiology 69:1, pages 171-199.
Crossref
Crossref
Viroj BoonyaratanakornkitEileen McGowanLori ShermanMichael A. ManciniBoris J. Cheskis & Dean P. Edwards. (2007) The Role of Extranuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle. Molecular Endocrinology 21:2, pages 359-375.
Crossref
Crossref
Kai-zheng GONG, Hui ZHANG, Jian-hai DU & You-yi ZHANG. (2007) Crosstalk between signaling pathways of adrenoreceptors and signal transducers and activators of transcription 3 (STAT3) in heart. Acta Pharmacologica Sinica 28:2, pages 153-165.
Crossref
Crossref
Andrea R. Daniel, Ming Qiu, Emily J. Faivre, Julie Hanson Ostrander, Andrew Skildum & Carol A. Lange. (2007) Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:2, pages 188-201.
Crossref
Crossref
M Salatino, W Beguelin, M G Peters, R Carnevale, C J Proietti, M D Galigniana, C G Vedoy, R Schillaci, E H Charreau, M C Sogayar & P V Elizalde. (2006) Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation. Oncogene 25:59, pages 7723-7739.
Crossref
Crossref
BHARAT B. AGGARWAL, GAUTAM SETHI, KWANG SEOK AHN, SANTOSH K. SANDUR, MANOJ K. PANDEY, AJAIKUMAR B. KUNNUMAKKARA, BOKYUNG SUNG & HARUYO ICHIKAWA. (2006) Targeting Signal-Transducer-and-Activator-of-Transcription-3 for Prevention and Therapy of Cancer. Annals of the New York Academy of Sciences 1091:1, pages 151-169.
Crossref
Crossref
Kwang Woon Kim, Robert W. Mutter, Carolyn Cao, Jeffrey M. Albert, Eric T. Shinohara, Konjeti R. Sekhar & Bo Lu. (2006) Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation. Molecular Cancer Therapeutics 5:11, pages 2659-2665.
Crossref
Crossref
Sujoy BhattacharyaRamesh M. RayLeonard R. Johnson. (2006) Integrin β3-mediated Src activation regulates apoptosis in IEC-6 cells via Akt and STAT3. Biochemical Journal 397:3, pages 437-447.
Crossref
Crossref
Chun-Liang Chen, Fu-Chuan Hsieh & Jiayuh Lin. (2006) Systemic evaluation of total Stat3 and Stat3 tyrosine phosphorylation in normal human tissues. Experimental and Molecular Pathology 80:3, pages 295-305.
Crossref
Crossref
Roxana Schillaci, Mariana Salatino, Juliana Cassataro, Cecilia J. Proietti, Guillermo H. Giambartolomei, Martín A. Rivas, Romina P. Carnevale, Eduardo H. Charreau & Patricia V. Elizalde. (2006) Immunization with Murine Breast Cancer Cells Treated with Antisense Oligodeoxynucleotides to Type I Insulin-Like Growth Factor Receptor Induced an Antitumoral Effect Mediated by a CD8+ Response Involving Fas/Fas Ligand Cytotoxic Pathway. The Journal of Immunology 176:6, pages 3426-3437.
Crossref
Crossref
Baolin Zhang, Huiqing Cao & Gadiparthi N. Rao. (2006) Fibroblast Growth Factor-2 Is a Downstream Mediator of Phosphatidylinositol 3-Kinase-Akt Signaling in 14,15-Epoxyeicosatrienoic Acid-induced Angiogenesis. Journal of Biological Chemistry 281:2, pages 905-914.
Crossref
Crossref
Sylvane Desrivières, Christian Kunz, Itamar Barash, Vida Vafaizadeh, Corina Borghouts & Bernd Groner. (2006) The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition. Journal of Mammary Gland Biology and Neoplasia 11:1, pages 75-87.
Crossref
Crossref